Samsara Vision

Samsara Vision Promotes Jason Herod to Chief Commercial Officer

FAR HILLS, N.J. – Samsara Vision today announced that Jason Herod, Vice President Commercial, International Markets, is promoted to Chief Commercial Officer, effective August 15, 2024. Samsara Vision is a privately held specialty medical device company focused on intraocular ophthalmic devices that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. Jason Herod joined Samsara Vision in August 2021 … Continue reading Samsara Vision Promotes Jason Herod to Chief Commercial Officer

Butterfly Network

Butterfly Network Appoints Steve Cashman as Chief Business Officer

Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum BURLINGTON, Mass. & NEW YORK – Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company’s successful launch of its third-generation Butterfly … Continue reading Butterfly Network Appoints Steve Cashman as Chief Business Officer

Infinimmune

Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer

SAN FRANCISCO – Infinimmune, a biotechnology company pioneering new methods for antibody drug discovery and development, announced today the appointment of Tim Sullivan, Ph.D., as Chief Business Officer. In this newly created role, Dr. Sullivan, who has decades of experience as a senior executive in the biotechnology and pharmaceutical industry, will be responsible for corporate and business development initiatives, as well as corporate and product … Continue reading Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer

Polestar

Polestar appoints Jean-Francois Mady as CFO

GOTHENBURG, Sweden – Polestar (Nasdaq: PSNY) continues to prepare itself for the next step in its development by appointing Jean-Francois Mady to the role of Chief Financial Officer (CFO), effective 21 October 2024. “I’m very excited to join Polestar, with its unique focus on design, electric performance and sustainability and look forward to supporting the Company’s exciting next phase.” Post this Jean-Francois brings 25 years … Continue reading Polestar appoints Jean-Francois Mady as CFO

Alentis

Alentis Appoints Jonathan Freve CFO

Jon brings more than 25 years of financial experience in the biotech sector BASEL, Switzerland – Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today that Jonathan (Jon) Freve has been appointed Chief Financial Officer effective immediately. Roberto Iacone, CEO of Alentis said, “Jon has a proven track record in successful IPOs, secondary offerings and … Continue reading Alentis Appoints Jonathan Freve CFO